Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect

Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect

US Patent 7781416 · Granted Aug 24, 2010

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Retinoid derivatives with antitumor activity2023
Carboxylated derivatives of glycosaminoglycans and use as drugs2022
Retinoid derivatives with antitumor activity2022
Carboxylated derivatives of glycosaminoglycans and use as drugs2022
Derivatives of N-desulfated glycosaminoglycans and use as drugs2022
Retinoid derivatives with antitumor activity2021
Derivatives of N-desulfated glycosaminoglycans and use as drugs2020
Carboxylated derivatives of glycosaminoglycans and use as drugs2020
Homogeneous formulation comprising omega-3 polyunsatured fatty acid and resverat2019
Aryl triazole compounds with antitumoural activity2016
Aryl triazole compounds with antitumoural activity2016
Anticancer combination of artemisinin-based drugs and other chemotherapeutic age2015